HEALTHCARE
Global E-Pharmacy Market - Industry Trends and Forecast to 2032
REPORT OVERVIEW
Global E-pharmacy Market, By Product (Skin Care, Dental, Cold And Flu, Vitamins, Weight Loss, Others), Type (Pharmacy Benefit Manager, Legitimate Internet Pharmacy, Illegal or Unethical Internet Pharmacy), Platform (App-Based, Web-Based), Payment Method (Cash on Delivery, Online Payment), Drug type (Prescription drug, Over-the-counter drug (OTC)), Business Model (Pharmacy, Direct), Product Types (Generic, Branded), Application (Hospitals, Personal Use, Government Research) Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2032.
Market Insights
The global E-pharmacy market size is valued to be USD xx million in 2023 and is expected to reach USD xx million by 2032, and it is expected to register a CAGR of xx% over the forecast period 2024-2032.
E-pharmacy, often known as electronic pharmacy, is an online platform that facilitates the sale and distribution of pharmaceutical products such as prescription pharmaceuticals, over-the-counter treatments, and healthcare supplies. These platforms offer convenience, competitive pricing, and a wider assortment of items by allowing customers to order pharmaceuticals from the comfort of their homes. The e-pharmacy market includes digital medicine sales management, such as logistics, online consultations, and secure payment systems. It provides a variety of services, including online prescriptions, drug delivery, and telehealth consultations. The need for better access to healthcare, particularly in rural regions, and the growing popularity of contactless services are the main drivers of this market. Regulatory issues and guaranteeing the validity of drugs continue to be significant features of the market.
The respective global report analyses market trends, consumer behaviour and industry dynamics to guide towards entry into new markets with ease. Also, it assists in tailoring market specific and related products and services to meet the needs, preferences, and expectations of target audience by delving into their psychology. The report also specializes with comprehensive and extensive competitive analysis which offers useful insights into competitor strengths, weaknesses, opportunities, and threats. The respective report offers exclusive insights into the potential impact of disruptive developments and technologies that are expected to completely transform corporate operations. The context includes tailor-made research solutions to create a stronger footprint in their particular industries thereby offering dedicated customized solutions according to the client needs which helps in addressing unique business challenges with more simplified and efficient decision-making solutions.
Market Dynamics
DRIVERS
- Rising in the numbers of internet users
- Growing need for remote patient monitoring services
RESTRAINTS
- Regulatory complexities and compliance issues across regions.
- Concerns over patient data privacy and security.
OPPORTUNITIES
- Aging population and increasing healthcare expenditures.
- Expansion of same-day and on-demand delivery services.
CHALLENGES
- Logistics and last-mile delivery challenges.
- Building trust and credibility in online pharmaceuticals.
SEGMENTATION
- Product
- Skin Care
- Dental
- Cold And Flu
- Vitamins
- Weight Loss
- Others
- Type
- Pharmacy Benefit Manager
- Legitimate Internet Pharmacy
- Illegal or Unethical Internet Pharmacy
- Platform
- App-Based
- Web-Based
- Payment Method
- Cash on Delivery
- Online Payment
- Drug type
- Prescription drug
- Over-the-counter drug (OTC)
- Business Model
- Pharmacy
- Direct
- Product Types
- Generic
- Branded
- Application
- Hospitals
- Personal Use
- Government Research
The respective global report is completely customizable specific to regions (North America, Europe, Asia-Pacific, South America, Middle East and Africa), countries, and segments as per the client requirements.
REGIONAL SEGMENTATION
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- The Netherlands
- Belgium
- Turkey
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Malaysia
- Australia
- Thailand
- Philippines
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Rest of South America
- Middle East and Africa
- Kingdom of Saudi Arabia
- South Africa
- U.A.E.
- Egypt
- Rest of Middle East and Africa
KEY MARKET PLAYERS
- Boehringer Ingelheim International GmbH
- AbbVie Inc
- Aurobindo Pharma
- Pfizer Inc.
- Walmart Inc.
- Walgreen Co.
- Express Scripts
- The Kroger Co.
- L Rowland & Co
- DocMorris
Table OF CONTENTS
- SECTION 1 - INTRODUCTION
- 1.1 Taxonomy
- 1.2 Market Overview
- 1.3 Currency and Limitations
- 1.3.1 Currency
- 1.3.2 Limitations
- 1.4 Key Competitors
- SECTION 2 - RESEARCH METHODOLOGY
- 2.1 Research Approach
- 2.2 Data Collection and Validation
- 2.2.1 Secondary Research
- 2.2.2 Primary Research
- 2.3 Market Assessment
- 2.3.1 Market Size Estimation
- 2.3.2 Bottom-up Approach
- 2.3.3 Top-down Approach
- 2.3.4 Growth Forecast
- 2.4 Market Study Assumptions
- 2.5 Data Sources
- SECTION 3 - EXECUTIVE SUMMARY
- 3.1 Global E-pharmacy Market, by Product
- 3.2 Global E-pharmacy Market, by Type
- 3.3 Global E-pharmacy Market, by Platform
- 3.4 Global E-pharmacy Market, by Payment Method
- 3.5 Global E-pharmacy Market, by Drug type
- 3.6 Global E-pharmacy Market, by Business Model
- 3.7 Global E-pharmacy Market, by Product Types
- 3.8 Global E-pharmacy Market, by Application
- 3.9 Global E-pharmacy Market, by Geography
- 3.10 Market Position Grid
- SECTION 4 - PREMIUM INSIGHTS
- 4.1 Regulatory Framework
- 4.1.1 Standards
- 4.1.2 Regulatory Landscape
- 4.2 Value Chain Analysis
- 4.3 Supply Chain Analysis
- 4.4 COVID-19 Impact
- 4.5 Russia-Ukraine War Impact
- 4.6 PORTER's Five Force Analysis
- 4.7 PESTLE Analysis
- 4.8 SWOT Analysis
- 4.9 Go to Market Strategy
- 4.10 Opportunity Orbit
- 4.11 Multivariate Modelling
- 4.12 Pricing Analysis
- SECTION 5 - MARKET DYNAMICS
- 5.1 Trends
- 5.1.1 Increased Adoption of Digital Health Solutions
- 5.1.2 Rapid increase in preventive healthcare
- 5.1.3 Trend 3
- 5.2 Drivers
- 5.2.1 Rising numbers of Internet users
- 5.2.2 Growing need for remote patient monitoring services
- 5.2.3 Driver 3
- 5.2.4 Driver 4
- 5.3 Restraints
- 5.3.1 Regulatory complexities and compliance issues across regions.
- 5.3.2 Concerns over patient data privacy and security.
- 5.3.3 Restraint 3
- 5.4 Opportunities
- 5.4.1 Aging population and increasing healthcare expenditures.
- 5.4.2 Expansion of same-day and on-demand delivery services.
- 5.4.3 Opportunity 3
- 5.4.4 Opportunity 4
- 5.5 Challenges
- 5.5.1 Logistics and last-mile delivery challenges.
- 5.5.2 Building trust and credibility in online pharmaceuticals.
- 5.5.3 Challenge 3
- SECTION 6 - GLOBAL E-PHARMACY MARKET, BY PRODUCT
- 6.1 Product Summary
- 6.2 Market Attractive Index
- 6.3 Global E-pharmacy Market, by Product (2019-2032)
- SECTION 7 - GLOBAL E-PHARMACY MARKET, BY TYPE
- 7.1 Type Summary
- 7.2 Market Attractive Index
- 7.3 Global E-pharmacy Market, by Type (2019-2032)
- SECTION 8 - GLOBAL E-PHARMACY MARKET, BY PLATFORM
- 8.1 Platform Summary
- 8.2 Market Attractive Index
- 8.3 Global E-pharmacy Market, by Platform (2019-2032)
- SECTION 9 - GLOBAL E-PHARMACY MARKET, BY PAYMENT METHOD
- 9.1 Payment Method Summary
- 9.2 Market Attractive Index
- 9.3 Global E-pharmacy Market, by Payment Method (2019-2032)
- SECTION 10 - GLOBAL E-PHARMACY MARKET, BY DRUG TYPE
- 10.1 Drug type Summary
- 10.2 Market Attractive Index
- 10.3 Global E-pharmacy Market, by Drug type (2019-2032)
- SECTION 11 - GLOBAL E-PHARMACY MARKET, BY BUSINESS MODEL
- 11.1 Business Model Summary
- 11.2 Market Attractive Index
- 11.3 Global E-pharmacy Market, by Business Model (2019-2032)
- SECTION 12 - GLOBAL E-PHARMACY MARKET, BY PRODUCT TYPES
- 12.1 Product Types Summary
- 12.2 Market Attractive Index
- 12.3 Global E-pharmacy Market, by Product Types (2019-2032)
- SECTION 13 - GLOBAL E-PHARMACY MARKET, BY APPLICATION
- 13.1 Application Summary
- 13.2 Market Attractive Index
- 13.3 Global E-pharmacy Market, by Application (2019-2032)
- SECTION 14 - GLOBAL E-PHARMACY MARKET, BY GEOGRAPHY
- 14.1 Regional Summary
- 14.2 Market Attractive Index
- 14.3 Global E-pharmacy Market, by Geography (2019-2032)
- SECTION 15 - NORTH AMERICA E-PHARMACY MARKET
- 15.1 North America Summary
- 15.2 Market Attractive Index
- 15.3 North America E-pharmacy Market, by Product (2019-2032)
- 15.4 North America E-pharmacy Market, by Type (2019-2032)
- 15.5 North America E-pharmacy Market, by Platform (2019-2032)
- 15.6 North America E-pharmacy Market, by Payment Method (2019-2032)
- 15.7 North America E-pharmacy Market, by Drug Type (2019-2032)
- 15.8 North America E-pharmacy Market, by Business Model (2019-2032)
- 15.9 North America E-pharmacy Market, by Product Types (2019-2032)
- 15.10 North America E-pharmacy Market, by Application (2019-2032)
- 15.11 North America E-pharmacy Market, by Country (2019-2032)
- 15.11.1 U.S.
- 15.11.2 Canada
- 15.11.3 Mexico
- 15.11.4 Rest of North America
- SECTION 16 - EUROPE E-PHARMACY MARKET
- 16.1 Europe Summary
- 16.2 Market Attractive Index
- 16.3 Europe E-pharmacy Market, by Product (2019-2032)
- 16.4 Europe E-pharmacy Market, by Type (2019-2032)
- 16.5 Europe E-pharmacy Market, by Platform (2019-2032)
- 16.6 Europe E-pharmacy Market, by Payment Method (2019-2032)
- 16.7 Europe E-pharmacy Market, by Drug Type (2019-2032)
- 16.8 Europe E-pharmacy Market, by Business Model (2019-2032)
- 16.9 Europe E-pharmacy Market, by Product Types (2019-2032)
- 16.10 Europe E-pharmacy Market, by Application (2019-2032)
- 16.11 Europe E-pharmacy Market, by Country (2019-2032)
- 16.11.1 Germany
- 16.11.2 U.K.
- 16.11.3 France
- 16.11.4 Italy
- 16.11.5 Spain
- 16.11.6 Russia
- 16.11.7 The Netherlands
- 16.11.8 Belgium
- 16.11.9 Turkey
- 16.11.10 Rest of Europe
- SECTION 17 - ASIA-PACIFIC E-PHARMACY MARKET
- 17.1 Asia-Pacific Summary
- 17.2 Market Attractive Index
- 17.3 Asia-Pacific E-pharmacy Market, by Product (2019-2032)
- 17.4 Asia-Pacific E-pharmacy Market, by Type (2019-2032)
- 17.5 Asia-Pacific E-pharmacy Market, by Platform (2019-2032)
- 17.6 Asia-Pacific E-pharmacy Market, by Payment Method (2019-2032)
- 17.7 Asia-Pacific E-pharmacy Market, by Drug Type (2019-2032)
- 17.8 Asia-Pacific E-pharmacy Market, by Business Model (2019-2032)
- 17.9 Asia-Pacific E-pharmacy Market, by Product Types (2019-2032)
- 17.10 Asia-Pacific E-pharmacy Market, by Application (2019-2032)
- 17.11 Asia-Pacific E-pharmacy Market, by Country (2019-2032)
- 17.11.1 China
- 17.11.2 India
- 17.11.3 Japan
- 17.11.4 South Korea
- 17.11.5 Singapore
- 17.11.6 Malaysia
- 17.11.7 Australia
- 17.11.8 Thailand
- 17.11.9 Philippines
- 17.11.10 Rest of Asia-Pacific
- SECTION 18 - SOUTH AMERICA E-PHARMACY MARKET
- 18.1 South America Summary
- 18.2 Market Attractive Index
- 18.3 South America E-pharmacy Market, by Product (2019-2032)
- 18.4 South America E-pharmacy Market, by Type (2019-2032)
- 18.5 South America E-pharmacy Market, by Platform (2019-2032)
- 18.6 South America E-pharmacy Market, by Payment Method (2019-2032)
- 18.7 South America E-pharmacy Market, by Drug Type (2019-2032)
- 18.8 South America E-pharmacy Market, by Business Model (2019-2032)
- 18.9 South America E-pharmacy Market, by Product Types (2019-2032)
- 18.10 South America E-pharmacy Market, by Application (2019-2032)
- 18.11 South America E-pharmacy Market, by Country (2019-2032)
- 18.11.1 Brazil
- 18.11.2 Argentina
- 18.11.3 Chile
- 18.11.4 Colombia
- 18.11.5 Rest of South America
- SECTION 19 - MIDDLE EAST AND AFRICA E-PHARMACY MARKET
- 19.1 Middle East and Africa Summary
- 19.2 Market Attractive Index
- 19.3 Middle East and Africa E-pharmacy Market, by Product (2019-2032)
- 19.4 Middle East and Africa E-pharmacy Market, by Type (2019-2032)
- 19.5 Middle East and Africa E-pharmacy Market, by Platform (2019-2032)
- 19.6 Middle East and Africa E-pharmacy Market, by Payment Method (2019-2032)
- 19.7 Middle East and Africa E-pharmacy Market, by Drug type (2019-2032)
- 19.8 Middle East and Africa E-pharmacy Market, by Business Model (2019-2032)
- 19.9 Middle East and Africa E-pharmacy Market, by Product Types (2019-2032)
- 19.10 Middle East and Africa E-pharmacy Market, by Application (2019-2032)
- 19.11 Middle East and Africa E-pharmacy Market, by Country (2019-2032)
- 19.11.1 Kingdom of Saudi Arabia
- 19.11.2 South Africa
- 19.11.3 U.A.E.
- 19.11.4 Egypt
- 19.11.5 Rest of Middle East and Africa
- SECTION 20 - COMPANY SHARE ANALYSIS
- 20.1 Global E-pharmacy Market, Company Share Analysis
- 20.2 North America E-pharmacy Market, Company Share Analysis
- 20.3 Europe E-pharmacy Market, Company Share Analysis
- 20.4 Asia-Pacific E-pharmacy Market, Company Share Analysis
- SECTION 21 - COMPANY PROFILES
- 21.1 Boehringer Ingelheim International GmbH
- 21.1.1 Company Snapshot
- 21.1.2 Financial Overview
- 21.1.3 Product Portfolio
- 21.1.4 Recent Developments
- 21.2 AbbVie Inc
- 21.2.1 Company Snapshot
- 21.2.2 Financial Overview
- 21.2.3 Product Portfolio
- 21.2.4 Recent Developments
- 21.3 Aurobindo Pharma
- 21.3.1 Company Snapshot
- 21.3.2 Financial Overview
- 21.3.3 Product Portfolio
- 21.3.4 Recent Developments
- 21.4 Pfizer Inc.
- 21.4.1 Company Snapshot
- 21.4.2 Financial Overview
- 21.4.3 Product Portfolio
- 21.4.4 Recent Developments
- 21.5 Walmart Inc.
- 21.5.1 Company Snapshot
- 21.5.2 Financial Overview
- 21.5.3 Product Portfolio
- 21.5.4 Recent Developments
- 21.6 Walgreen Co.
- 21.6.1 Company Snapshot
- 21.6.2 Financial Overview
- 21.6.3 Product Portfolio
- 21.6.4 Recent Developments
- 21.7 Express Scripts
- 21.7.1 Company Snapshot
- 21.7.2 Financial Overview
- 21.7.3 Product Portfolio
- 21.7.4 Recent Developments
- 21.8 The Kroger Co.
- 21.8.1 Company Snapshot
- 21.8.2 Financial Overview
- 21.8.3 Product Portfolio
- 21.8.4 Recent Developments
- 21.9 L Rowland & Co
- 21.9.1 Company Snapshot
- 21.9.2 Financial Overview
- 21.9.3 Product Portfolio
- 21.9.4 Recent Developments
- 21.10 DocMorris
- 21.10.1 Company Snapshot
- 21.10.2 Financial Overview
- 21.10.3 Product Portfolio
- 21.10.4 Recent Developments
- SECTION 22 - RELATED REPORTS
- SECTION 23 - DISCLAIMER
RESEARCH METHODOLOGY
The research methodology employed in Uniprism Market Research involves four basic steps namely research and data collection, data pre-processing, modeling and forecasting, quality assurance and output.
RESEARCH AND DATA COLLECTION
A tripod model research technique is followed for research and data collection in which various approaches such as primary research, secondary research, and product mapping are considered.
Primary research basically involves the process of conducting personalized interviews with market related professionals of major market players, investors, distributors, vendors and many more.
The secondary research include data published by government, annual reports, press releases, investor presentations of companies, white papers, certified publications, annual manufacturing limit of the respective industries related to the market, production consumption analysis of certain products respective to the market and many more.
Below mention are few of the sources which we have considered while estimating the market size:
For instance,
- Research articles published on Technium
- Science and MDPI
- Research publications by government approved associations and societies
Product mapping means the process of mapping the list of products that a key player contributes to the market as well as estimating the revenue of those products in order to define the Global Company share analysis of the respective Global Company in global, regional, and country level markets.
DATA PRE-PROCESSING
The term "data pre-processing" refers to the collection of procedures and methods used to clean, modify, and make ready for analysis the raw data gathered during research and data collection. The completion of this phase is necessary to guarantee that the data are reliable, consistent, and appropriate for statistical analysis and other data-driven tasks. The data pre-processing ensures that the information gathered from research and data collection is comparable and expressed in standard units, by the integration of missing data pointers and algorithmic approaches.
MODELING AND FORECASTING
The process of developing mathematical, statistical, or computational representations of real-world occurrences or relationships is known as modelling. These models are intended to replicate and explain market interactions, interdependence, and dynamics. These models are used by Uniprism Market Research to acquire a better knowledge of numerous market characteristics such as customer preferences, pricing elasticity, competition dynamics, and more. Depending on the individual study aims, many types of models are utilized, such as regression models, econometric models, decision tree models, and machine learning models.
Forecasting is the process of predicting future market conditions, trends, and occurrences using past data and models. Forecasting is used by Uniprism Market Research to estimate future sales, demand for products or services, market growth, and other important performance metrics. Forecasting accurately can assist organizations in making educated decisions about resource allocation, pricing, inventory management, and marketing tactics.
We create standardized bottom-up or top-down models that scale by leveraging data science and machine learning technology. All our market models consider the unique market characteristics of each country. Forecasting is based on major market indicators and a combination of traditional methodologies, such as exponential smoothing, time series analysis, regression analysis, and more modern techniques such as machine learning algorithms are all forecasting methodologies. The method chosen is determined on the nature of the data and the specific forecasting aims.
QUALITY ASSURANCE AND OUTPUT
Quality assurance and output involves the process of validation, adjustments, further publications of key market indicators. Extensive plausibility and consistency tests are performed on derived time series to ensure the high degree of quality of our market analysis. This quality assurance procedure also includes rigorous inspection, validation, and editing by an experienced management team to assure the dependability of the published data.